Universal Health Services plans to acquire Talkspace for $835 million to create a national behavioral health platform that ...

In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

A Vertex Pharmaceuticals immunology drug in clinical testing for a rare kidney disease is catching up to others that work in a similar way, but the company contends its therapy can be best in its ...

Data is vital in advancing healthcare, as it helps providers understand patients better and make more educated decisions on their care. However, the vast majority of health data isn’t used, according ...

The rare disorder Duchenne muscular dystrophy is treated with genetic medicines that get skeletal muscle cells to produce a version of the key protein that they lack. Though these therapies slow ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

New Mexico-based Presbyterian Healthcare Services is scaling its use of GW RhythmX’s AI-powered precision care platform, with 200 of Presbyterian’s primary care clinicians now using the system to help ...

Convergence and consolidation, mergers and acquisitions, it’s all happening in healthcare. The week kicks off with a variation on these themes: a double acquisition-merger starring employer wellness ...

Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings acromegaly patients the choice of a once-daily pill that ...

Servier is expanding its cancer drug prospects through the $2.5 billion acquisition of Day One Biopharmaceuticals, a biotech with a commercialized therapy for a type of pediatric glioma and ...